Serina Therapeutics, based in Alameda, California, is a clinical-stage biotechnology company developing drug candidates for neurological diseases, focusing on SER-252 for Parkinson's Disease. The company went public on November 29, 2018, and employs four people.
SER filed a patent for "polyoxazoline-drug conjugates with novel pharmacokinetic properties" on Fri, May 3, 2024. The patent was officially published on Thu, September 26, 2024.
📡️ Health Care
Patents
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
